Skip to Main Content

Paper Details

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study.
Clin Transl Gastroenterol
19
2021
80 gene, ATM, BRCA1, BRCA2, CHEK2, NBN, PALB2, PC, PGV, PGVs, Pancreatic Cancer, RAD51C, cancer, carbohydrate, carbohydrate antigen 19-9, familial cancer, germline, germline variants, homologous recombination repair genes, multigene panel, pancreatic cancer, patients, tumor

Datasets

Release 1.2